Work

Intratumoral checkpoint subversion as a strategy for minimizing adverse effects

Year: 2014

Type: article

Abstract: One of the most significant clinical advances in cancer immunotherapy to date has been the targeting of the immune “checkpoints” that inhibit effector T-cell function. Cytotoxic T lymphocyte-associ...

Source: OncoImmunology

DOI: 10.4161/onci.27580

Authors: Leah Alabanza, Sacha Gnjatic, Nina Bhardwaj, Joshua Brody

Institution: Icahn School of Medicine at Mount Sinai

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,913

OpenAlex ID: W2329014100

FWCI:

Cites: 22

Cited by: 3

Related to: 10